Effect of the acylation of TEAD4 on its interaction with co‐activators YAP and TAZ
Yannick Mesrouze(Novartis (Switzerland)), Patrick Chêne(Novartis (Switzerland))
Cited by 69
Related Papers
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent <i>in vivo</i> antitumor activity
|Molecular Cancer Therapeutics|2008|1.1k
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
|Breast Cancer Research|2008|224
Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue
|BMC Chemical Biology|2009|81